Fate of Ingested Clostridium difficile Spores in Mice

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Howerton, Amber ^a   Patra, Manomita ^a   Abel Santos, Ernesto ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; CAMSA; CHENODEOXYCHOLIC ACID; ETHYLCHOLATE; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL SHEDDING; BACTERIAL SPORE; BIFIDOBACTERIUM LONGUM; BIOACCUMULATION; CECUM; CHEMOPROPHYLAXIS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLON; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG METABOLISM; DRUG PENETRATION; DRUG STABILITY; ESCHERICHIA COLI; FEMALE; IN VITRO STUDY; INGESTION; INTESTINE TRANSIT TIME; LACTOBACILLUS GASSERI; MOUSE; NONHUMAN; PROTECTION; SPORE GERMINATION;

ANIMALS; BACTERIAL TOXINS; CACO-2 CELLS; CECUM; CELL DEATH; CELL MEMBRANE PERMEABILITY; CERCOPITHECUS AETHIOPS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CYTOPROTECTION; FECES; HUMANS; HYDROLASES; INTESTINES; MICE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; SPORES, BACTERIAL; TAUROCHOLIC ACID; TIME FACTORS; VERO CELLS;

EID: 84883353961     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072620     Document Type: Article

References (30)

1. Cohen S, Gerding D, Johnson S, Kelly CP, Loo V, et al. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infection Control and Hospital Epidemiology 31: 431-455.
2. Kachrimanidou M, Malisiovas N, (2012) Clostridium difficile infection: A comprehensive review. Critical Reviews in Microbiology 37: 178-187.
3. Speight S, Moy A, Macken S, Chitnis R, Hoffman PN, et al. (2011) Evaluation of the sporicidal activity of different chemical disinfectants used in hospitals against Clostridium difficile. Journal of Hospital Infection 79: 18-22.
4. Rolfe RD, Helebian S, Finegold SM, (1981) Bacterial interference between Clostridium difficile and normal fecal flora. Journal of Infectious Diseases 143: 470-475.
5. Setlow P, (2003) Spore germination. Current Opinions in Microbiology 6: 550-556.
6. Sorg JA, Sonenshein AL, (2008) Bile salts and glycine as cogerminants for Clostridium difficile spores. Journal of Bacteriology 190: 2505-2512.
7. Ramirez N, Liggins M, Abel-Santos E, (2010) Kinetic evidence for the presence of putative germination receptors in C. difficile spores. Journal of Bacteriology 192: 4215-4222.
8. Howerton A, Ramirez N, Abel-Santos E, (2011) Mapping interactions between germinants and Clostridium difficile spores. Journal of Bacteriology 193: 274-282.
9. Sorg JA, Sonenshein AL, (2009) Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. Journal of Bacteriology 191: 1115-1117.
10. Sorg JA, Sonenshein AL, (2010) Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. Journal of Bacteriology 192: 4983-4990.
11. Howerton A, Patra M, Abel-Santos E, (2013) A new strategy for the prevention of Clostridium difficile infections. Journal of Infectious Diseases 207: 1498-1504.
12. Best EL, Freeman J, Wilcox MH (2012) Models for the study of Clostridium difficile infection. Gut Microbes 3: 145-167.
13. Buckley AM, Spencer J, Candlish D, Irvine JJ, Douce GR, (2011) Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291. Journal of Medical Microbiology 60: 1174-1180.
14. Freeman J, Baines SD, Jabes D, Wilcox MH, (2005) Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection. Journal of Antimicrobial Chemotherapy 56: 717-725.
15. Walum E (1998) Acute oral toxicity. Environmental Health Perspectives 106: 497-503.
16. Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, et al. (2008) A Mouse Model of Clostridium difficile-Associated Disease. Gastroenterology 135: 1984-1992.
17. Begley M, Gahan CG, Hill C (2005) The interaction between bacteria and bile. FEMS Microbiological Reviews 29: 625-651.
18. Teksin Z, Seo P, Polli J, (2010) Comparison of drug permeabilities and BCS classification: Three lipid-component PAMPA system method versus Caco-2 monolayers. The AAPS Journal 12: 238-241.
19. Sutton PA, Li S, Webb J, Solomon K, Brazier J, et al. (2008) Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function. Clinical and Experimental Immunology 153: 439-447.
20. Liggins M, Ramirez N, Magnuson N, Abel-Santos E, (2011) Progesterone analogs influence germination of Clostridium sordellii and Clostridium difficile spores in vitro. Journal of Bacteriology 193: 2776-2783.
21. Klaassen CD, (1973) Comparison of the toxicity of chemicals in newborn rats to bile duct-ligated and sham-operated rats and mice. Toxicology and Applied Pharmacology 24: 37-44.
22. Vollaard EJ, Clasener HA, (1994) Colonization resistance. Antimicrobial Agents and Chemotherapy 38: 409-414.
23. Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, et al. (2011) The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes 2: 145-158.
24. Takano M, Hasegawa R, Fukuda T, Yumoto R, Nagai J, et al. (1998) Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. European Journal of Pharmacology 358: 289-294.
25. Setlow P, Liu J, Faeder JR (2012) Heterogeneity in Bacterial Spore Populations. In: Abel-Santos E, editor. Bacterial Spores: Current Research and Applications. Norfolk: Caister Academic Press. 199-214.
26. Sun X, Wang H, Zhang Y, Chen K, Davis B, et al. (2011) Mouse Relapse Model of Clostridium difficile Infection. Infection and Immunity 79: 2856-2864.
27. Yan R, Ko NL, Li S-L, Tam YK, Lin G, (2008) Pharmacokinetics and Metabolism of Ligustilide, a Major Bioactive Component in Rhizoma Chuanxiong, in the Rat. Drug Metabolism and Disposition 36: 400-408.
28. Tanaka H, Doesburg K, Iwasaki T, Mierau I, (1999) Screening of lactic acid bacteria for bile salt hydrolase activity. Journal of Dairy Science 82: 2530-2535.
29. Strober W (2001) Trypan Blue Exclusion Test of Cell Viability. Current Protocols in Immunology: John Wiley & Sons, Inc. pp. Appendix 3B.
30. Crouch SP, Kozlowski R, Slater KJ, Fletcher J (1993) The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. Journal of Immunological Methods 160: 81-88.